MedTrace Logo

The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease

NCT05217459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2025-05-21

No results posted yet for this study

Summary

The primary objective of this trial is to evaluate the safety and efficacy of SINOMED IS- DES in patients with symptomatic intracranial atherosclerotic stenosis.

Conditions

  • Intracranial Arterial Diseases
  • Stent Restenosis
  • Percutaneous Transluminal Angioplasty

Interventions

DEVICE

Self-expanding intracranial drug stent system

All patients receive Percutaneous transluminal angioplasty and stenting with self-expanding intracranial drug stent system (Temporary abbreviations: SINOMED IS-DES)

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • Sinomed Neurovita Technology Inc.

    lead INDUSTRY

Principal Investigators

  • jianming Liu, M.D/Ph.D · Changhai Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-04
Primary Completion
2023-08-17
Completion
2024-03-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217459 on ClinicalTrials.gov